XML 28 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900
Deferred Grant Income
12 Months Ended
Sep. 30, 2015
Deferred Revenue Disclosure [Abstract]  
Deferred Grant Income
Note 5 Deferred Grant Income

 

During the year ended September 30, 2015, the Company was awarded grant funding in the amount of $286,455, of which the Company received $71,614 during the year ended September 30, 2015 and the remainder will be received in equal semi-annual instalments over the 24 month commitment. The grant was received in exchange for a commitment to provide research and development for preclinical validation of Sigma-1 receptor agonism as potential treatment for Parkinsons disease.

 

The grant income was deferred and is being amortized as an increase to other income over a two year period using the straight line method over the grant term.